Experts say this new migraine medication, the first in 50 years, shows great promise. Here’s what you need to know, including the cost implications
New research shows that health insurers won’t be able to curb costs and improve outcomes through accountable care organizations (ACOs). At least, they won’t be able to realize savings any time soon.
The conditions that are the biggest drivers of female mortality, some preventive measures, and the latest treatment advances.
For the first time, Managed Healthcare Executive has selected 10 emerging healthcare industry leaders, working in the areas of pharmacy, health plans, health systems, and technology.
The goal is to help ensure that prescription drug marketing information for consumers and healthcare providers is truthful and balanced. Here’s what the agency plans to research.
A new study looks at how U.S. healthcare spending compares to 10 other high-income countries. Here are three of the biggest areas in which U.S. spending is higher.
Experts weigh in on a recent lawsuit against PBMs, whether similar lawsuits will crop up, and the likely outcomes.
Your net promoter score could be influencing your business. Here’s what it is and how to improve it.
Genetic testing is playing a growing role in diagnosing and treating diseases, particularly when it comes to certain cancers and rheumatic conditions.
Anthem’s decision has sparked criticism and concern, but could it reduce healthcare spending? Experts weigh in.